Post Job

PacBio's revenue is $128.3 million.

What is PacBio's revenue?

PacBio's annual revenue is $128.3M. Zippia's data science team found the following key financial metrics about PacBio after extensive research and analysis.
  • PacBio's revenue growth from 2009 to 2022 is 94,940.0%.
  • PacBio has 400 employees, and the revenue per employee ratio is $320,760.
  • PacBio's peak quarterly revenue was $55.7M in 2023(q3).
  • PacBio peak revenue was $130.5M in 2021.
  • PacBio annual revenue for 2021 was 130.5M, 65.43% growth from 2020.
  • PacBio annual revenue for 2022 was 128.3M, -1.69% growth from 2021.

On This Page

Most Recent Quarter Revenue
$55.7M (Q3'2023)
Company Most Recent Quarter Revenue
Peak Revenue
$130.5M (2021)
Company Peak Revenue
Revenue / Employee
$320,760
Company Revenue / Employee
Work At PacBio?
Share Your Experience
Most Recent Quarter Revenue
$55.7M (Q3'2023)
Company Most Recent Quarter Revenue
Peak Revenue
$130.5M (2021)
Company Peak Revenue
Revenue / Employee
$320,760
Company Revenue / Employee

PacBio historical revenue

PacBio's peak revenue was $130.5M in 2021. The peak quarterly revenue was $55.7M in 2023(q3).

PacBio's revenue increased from $135.0k in 2009 to $128.3M currently. That's a 94,940.0% change in annual revenue.

PacBio annual revenue

$131M
$104M
$78M
$52M
$26M
$0
2017
2018
2019
2020
2021
2022

PacBio annual revenue over time

Fiscal Year / YearPacBio Revenue
2009$135,000
2010$1.7M
2011$33.9M
2012$26.0M
2013$28.2M
2014$60.6M
2015$92.8M
2016$90.7M
2017$93.5M
2018$78.6M
2019$90.9M
2020$78.9M
2021$130.5M
2022$128.3M

Rate PacBio's financial transparency

Zippia waving zebra

PacBio annual growth

PacBio saw the greatest revenue growth in 2011, when revenue increased by 1,922.88%.

PacBio had the lowest revenue growth in 2012, when revenue changed by -23.27%.

PacBio annual growth rate over time

YearPacBio Growth
2010
1140%
2011
1923%
2012
-23%
2013
8%
2014
115%
2015
53%
2016
-2%
2017
3%
2018
-16%
2019
16%
2020
-13%
2021
65%
2022
-2%

PacBio quarterly revenue over time

  • Q1
  • Q2
  • Q3
  • Q4
$56M
$45M
$33M
$22M
$11M
$0
2019
2020
2021
2022
2023

PacBio quarterly growth rate over time

YearQ1Q2Q3Q4
2010--$220,000$280,000
2011$270,000$10.6M$10.5M$12.4M
2012$10.0M$7.3M$2.8M$5.9M
2013$5.6M$6.0M$7.4M$9.1M
2014$11.6M$11.4M$20.6M$16.9M
2015$17.6M$24.9M$13.9M$36.3M
2016$19.1M$20.7M$25.1M$25.7M
2017$24.9M$20.1M$23.5M$24.9M
2018$19.4M$21.6M$18.2M$19.5M
2019$16.4M$24.6M$21.9M$27.9M
2020$15.6M$17.1M$19.1M$27.1M
2021$29.0M$30.6M$34.9M$36.0M
2022$33.2M$35.5M$32.3M$27.4M
2023$38.9M$47.6M$55.7M-

PacBio Jobs Nearby

Do you work at PacBio?

Did PacBio meet its revenue projections?

PacBio Financial Information

CEOChristian O. Henry
IndustryPharmaceuticals, Biotechnology & Life Sciences
Company TypePublic
Employees Number400
Date Founded2004
HeadquartersMenlo Park, California
Number of Locations2
Revenue$128.3M
Net Income-$314,248,000
Gross Proft$49.0M (2022)
PE Ratio-3.25
Tax Rate0.3%
Market Capitalization$1.0B
Total Assets$1,767,086,000
TickerPACB

PacBio Jobs You Might Like

PacBio Financing

PacBio received early financing of $4.5M on 2004-07-28.

SeriesRound SizeDate
Series B$4.5M07/2004
Series C$7.7M08/2005
Series D$50M01/2007
Series E$100M07/2008
Series E$68M10/2009
Series F$109M07/2010
Post Ipo Debt$20.5M02/2013
Post Ipo Debt$900M02/2021

PacBio Investors

InvestorsSecurity Type
Big Red VenturesSeries B
Mohr Davidow VenturesSeries C
ALLOY VENTURESSeries C
Kleiner PerkinsSeries C
Mohr Davidow VenturesSeries D
ALLOY VENTURESSeries D
Kleiner PerkinsSeries D
Maverick VenturesSeries D
Mohr Davidow VenturesSeries E
Redmile GroupSeries E
Intel CapitalSeries E
ALLOY VENTURESSeries E
DAG VenturesSeries E
ALLIANCEBERNSTEIN L.P.Series E
Kleiner PerkinsSeries E
T. Rowe Price Group, Inc.Series E
Deerfield Capital ManagementSeries E
Maverick VenturesSeries E
Morgan StanleySeries E
Sutter Hill VenturesSeries E
Wellcome TrustSeries E
Intel CapitalSeries E
MONSANTO CO NEWSeries E
DeerfieldSeries E
ALLIANCEBERNSTEIN L.P.Series E
Mohr Davidow VenturesSeries E
Ontario Teachers Pension PlanSeries E
ALLOY VENTURESSeries E
DAG VenturesSeries E
Kleiner PerkinsSeries E
T. Rowe Price Group, Inc.Series E
Maverick VenturesSeries E
Morgan StanleySeries E
Mohr Davidow VenturesSeries F
Sutter Hill VenturesSeries F
Intel CapitalSeries F
ALLOY VENTURESSeries F
DAG VenturesSeries F
DeerfieldSeries F
GEN PROBE INCSeries F
ALLIANCEBERNSTEIN L.P.Series F
Kleiner PerkinsSeries F
Maverick VenturesSeries F
Morgan StanleySeries F
DeerfieldPost Ipo Debt
SoftBank Group CorpPost Ipo Debt

PacBio competitors

PacBio Revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of PacBio, including salaries, political affiliations, employee data, and more, in order to inform job seekers about PacBio. The employee data is based on information from people who have self-reported their past or current employments at PacBio. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by PacBio. The data presented on this page does not represent the view of PacBio and its employees or that of Zippia.

PacBio may also be known as or be related to PACIFIC BIOSCIENCES OF CALIFORNIA, INC., PacBio, Pacific Biosciences, Pacific Biosciences of California Inc, Pacific Biosciences of California Inc. and Pacific Biosciences of California, Inc.